Norges Bank
AMED

Norges Bank’s Amedisys AMED Stock Holding History

Norges Bank’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-902,135
Closed -$88.8M – 84
2025
Q2 		$88.8M Buy
902,135
+12,742
+1% +$1.21M 0.01% 749
2025
Q1 		$82.4M Sell
889,393
-25,471
-3% -$2.35M 0.01% 752
2024
Q4 		$83.1M Buy
914,864
+525,471
+135% +$48.3M 0.01% 762
2024
Q3 		$37.6M Hold
389,393
– – 0.01% 1072
2024
Q2 		$35.7M Buy
389,393
+10,416
+3% +$966K 0.01% 1046
2024
Q1 		$34.9M Buy
378,977
+20,968
+6% +$1.96M 0.01% 1087
2023
Q4 		$34M Buy
358,009
+216,174
+152% +$20.2M 0.01% 1084
2023
Q3 		$13.2M Buy
141,835
+100,000
+239% +$9.24M ﹤0.01% 1371
2023
Q2 		$3.83M Sell
41,835
-282,187
-87% -$23.1M ﹤0.01% 1779
2023
Q1 		$23.8M Buy
324,022
+12,624
+4% +$1.09M 0.01% 1208
2022
Q4 		$26M Buy
311,398
+25,235
+9% +$2.28M 0.01% 1141
2022
Q3 		$27.7M Buy
286,163
+1,263
+0.4% +$151K 0.01% 1053
2022
Q2 		$29.9M Buy
284,900
+14,256
+5% +$1.82M 0.01% 1034
2022
Q1 		$46.6M Sell
270,644
-28,944
-10% -$4.32M 0.01% 930
2021
Q4 		$48.5M Sell
299,588
-22,466
-7% -$3.61M 0.01% 952
2021
Q3 		$48M Buy
322,054
+52,550
+19% +$10.9M 0.01% 942
2021
Q2 		$66M Buy
269,504
+413
+0.2% +$108K 0.01% 813
2021
Q1 		$71.3M Sell
269,091
-4,384
-2% -$1.24M 0.02% 773
2020
Q4 		$80.2M Sell
273,475
-66,008
-19% -$16.9M 0.02% 694
2020
Q3 		$80.3M Sell
339,483
-10,989
-3% -$2.5M 0.02% 622
2020
Q2 		$69.6M Sell
350,472
-186,791
-35% -$34.8M 0.02% 653
2020
Q1 		$98.6M Sell
537,263
-7,334
-1% -$1.3M 0.04% 437
2019
Q4 		$90.9M Hold
544,597
– – 0.03% 584
2019
Q3 		$71.3M Buy
544,597
+24,746
+5% +$3.22M 0.02% 667
2019
Q2 		$63.1M Sell
519,851
-25,750
-5% -$3.06M 0.02% 743
2019
Q1 		$67.3M Sell
545,601
-37,969
-7% -$4.77M 0.02% 674
2018
Q4 		$68.3M Buy
583,570
+42,259
+8% +$4.98M 0.03% 587
2018
Q3 		$67.6M Hold
541,311
– – 0.02% 671
2018
Q2 		$46.3M Buy
541,311
+33,035
+6% +$2.43M 0.02% 888
2018
Q1 		$30.7M Hold
508,276
– – 0.01% 1132
2017
Q4 		$26.8M Buy
508,276
+56,245
+12% +$2.96M 0.01% 1268
2017
Q3 		$25.3M Buy
452,031
+92,338
+26% +$4.88M 0.01% 1289
2017
Q2 		$22.6M Sell
359,693
-23,257
-6% -$1.35M 0.01% 1321
2017
Q1 		$19.6M Buy
382,950
+66,671
+21% +$3.18M 0.01% 1408
2016
Q4 		$13.5M Buy
316,279
+34,053
+12% +$1.45M 0.01% 1544
2016
Q3 		$12.8M Sell
282,226
-73,170
-21% -$3.65M 0.01% 1513
2016
Q2 		$17.9M Buy
355,396
+10,515
+3% +$531K 0.01% 1271
2016
Q1 		$16.7M Hold
344,881
– – 0.01% 1273
2015
Q4 		$13.6M Hold
344,881
– – 0.01% 1402
2015
Q3 		$13.1M Buy
344,881
+114,600
+50% +$4.83M 0.01% 1398
2015
Q2 		$9.15M Sell
230,281
-71,132
-24% -$2.22M ﹤0.01% 1674
2015
Q1 		$8.07M Sell
301,413
-14,912
-5% -$421K ﹤0.01% 1739
2014
Q4 		$9.28M Hold
316,325
– – ﹤0.01% 1674
2014
Q3 		$6.38M Sell
316,325
-316,325
-50% -$6.1M ﹤0.01% 1827
2014
Q2 		$10.6M Buy
632,650
+316,325
+100% +$4.48M ﹤0.01% 1924
2014
Q1 		$4.71M Hold
316,325
– – ﹤0.01% 1907
2013
Q4 		$4.63M Hold
316,325
– – ﹤0.01% 1916
2013
Q3 		$5.45M Hold
316,325
– – ﹤0.01% 1860
2013
Q2 		$3.68M Buy
+316,325
New +$3.62M ﹤0.01% 1969

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Norges Bank's AMED Position: Q3 2025 in Review

Norges Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 902,135 shares — an estimated $88.8M sold.

Norges Bank first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $98.6M in Q1 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Norges Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Norges Bank sold 902,135 Amedisys shares in Q3 2025, an estimated $88.8M.
  • Norges Bank first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Norges Bank's Amedisys position peaked at $98.6M in Q1 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.